High density lipoprotein (HDL) cholesterol is an important risk factor for coronary heart
disease, and HDL exerts various potentially antiatherogenic properties, including the …

Plasma levels of HDL cholesterol (HDL-C) predict the risk of cardiovascular disease at the
epidemiological level, but a direct causal role for HDL in cardiovascular disease remains …

Abstract Paraoxonase 1 (PON1) is a hydrolytic enzyme with wide range of substrates, and
capability to protect against lipid oxidation. Despite of the large number of compounds that …

Background Nutrigenetics studies the role of genetic variation on interactions between diet
and health, aiming to provide more personalized dietary advice. However, replication has …

High‐density lipoprotein (HDL) is one of the major carriers of cholesterol in the blood. It
attracts particular attention because, in contrast with other lipoproteins, many physiological …

Apolipoprotein (Apo) AI and apo A-II are the major apolipoproteins of HDL. It is clearly
demonstrated that there are inverse relationships between HDL–cholesterol and apo AI …

Our understanding of apolipoprotein A-II (apoA-II) physiology is much more limited than that
of apoA-I. However, important and rather surprising advances have been produced, mainly …

Apolipoprotein A-II (apoA-II), the second major high-density lipoprotein (HDL)
apolipoprotein, has been linked to familial combined hyperlipidemia. Human apoA-II …

Reduced levels of HDL cholesterol (HDL-C) are a strong independent predictor of coronary
artery disease (CAD) risk. The major anti-atherogenic function of HDL is to mediate reverse …

Abstract Background: Apolipoprotein A-II (APOA2) plays an ambiguous role in lipid
metabolism, obesity, and atherosclerosis. Methods: We studied the association between a …